Control de calidad de moxifloxacino de 400mg/tableta realizado en el laboratorio de control de calidad hypatia s.a.”

Abstract

This report details the method of analysis for the finished product of Moxifloxacin tablets, medicine used to treat multidrug TB in our health system. Analyses were performed in the laboratory quality control Hypatia SA nationally accredited by the National Institute of Health. Analyses were performed with the reference to the manufacturer's internal methodology, which is a validated method for the same official standards as well as the U.S. Pharmacopoeia and British Pharmacopoeia. Analyses performed were: appearance, average weight, identification, content and content uniformity, in which results were obtained under the same so it is concluded that this product meets the quality requirements and are suitable for use in the treatment of multidrug tuberculosis in our country